PlainPatent
USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Institut National De La Sante Et De La Recherche Medicale (inserm)

USPTO PatentsView assignee record - 617 granted patents across 89 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).

Explore the portfolio See the ranking
617
Total patents granted
89
CPC technology areas
13.6
Avg claims per patent
+25%
5-year filing velocity

The verdict

Institut holds 617 US patents across 89 technology areas, rank #738 of 50,000 tracked assignees.

#738
of 50,000 US assignees by volume
Top 3%
by Innovation Score (61.8/100)
13.6
avg claims per patent
+25%
filing velocity, last 5 yrs

Portfolio overview

Institut National De La Sante Et De La Recherche Medicale (inserm) has been granted 617 US utility patents between 2015 and 2025, placing Institut National De La Sante Et De La Recherche Medicale (inserm) at rank #738 across all assignees tracked by PlainPatent. This portfolio spans 89 distinct Cooperative Patent Classification (CPC) subclasses, averaging 13.6 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a Foreign Corporation, Institut National De La Sante Et De La Recherche Medicale (inserm) is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Institut sits between Baxter International Inc. (620 patents, rank #734) and Uchicago Argonne, Llc (616 patents, rank #742) - the closest US assignees by grant volume. The composite Innovation Score of 61.8/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 343 grants, compared with 274 in the 2015–2019 window, a +25% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Institut National De La Sante Et De La Recherche Medicale (inserm)'s 13.6 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 89 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Institut National De La Sante Et De La Recherche Medicale (inserm) against peers pursuing similar technology classes.

Who files at Institut's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Institut holds 617 patents at rank #738, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Institut

By rank, the assignees closest to #738 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Institut's primary technology class.

Institut's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

62 Top 3% higher than 97% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). Below this entry. 50–60: 5,058 US assignees (10%). Below this entry. 60–70: 1,537 US assignees (3%). This entry sits in this band. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

4050607080 20152016201720182019202020212022202320242025 43
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Institut National De La Sante Et De La Recherche Medicale (inserm) patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 57 9.2%
2016 52 8.4%
2017 60 9.7%
2018 52 8.4%
2019 53 8.6%
2020 77 12.5%
2021 49 7.9%
2022 62 10.0%
2023 69 11.2%
2024 43 7.0%
2025 43 7.0%

Which technologies does Institut National De La Sante Et De La Recherche Medicale (inserm) patent most?

Top 15 of 89 technology areas

Patent Moat Analysis

Portfolio Volume Moderate
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Growing

Where it ranks

Overall rank by patents

#738

Across all tracked assignees

Innovation Score

61.8 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Institut National De La Sante Et De La Recherche Medicale (inserm) hold?
Institut National De La Sante Et De La Recherche Medicale (inserm) holds 617 US granted patents filed between 2015 and 2025, spanning 89 technology areas.
What is Institut National De La Sante Et De La Recherche Medicale (inserm)'s Innovation Score?
Institut National De La Sante Et De La Recherche Medicale (inserm) has an Innovation Score of 61.8 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Institut National De La Sante Et De La Recherche Medicale (inserm) focus on?
Institut National De La Sante Et De La Recherche Medicale (inserm)'s top technology area is A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES) with 361 patents. The company has filed patents in 89 CPC subclasses total.
Is Institut National De La Sante Et De La Recherche Medicale (inserm)'s patent filing rate increasing or decreasing?
Institut National De La Sante Et De La Recherche Medicale (inserm)'s recent filing velocity is +25% compared to the prior five-year period. The company is maintaining or growing its patent output.
What does claim depth mean for Institut National De La Sante Et De La Recherche Medicale (inserm)'s patents?
Institut National De La Sante Et De La Recherche Medicale (inserm)'s patents average 13.6 claims each. This falls within the standard range, providing solid legal coverage.
How is the Institut National De La Sante Et De La Recherche Medicale (inserm) patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Institut's 617 grants land it in the top 3% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - Institut ranks #738 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in A61K - see who else leads that technology area. A61K leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.